← Back to Search

Behavioral Intervention

Behavioral Activation (BA) for Alcoholism

N/A
Waitlist Available
Led By Eric B Elbogen, PhD
Research Sponsored by RTI International
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be 18 to 65 years old
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 3 months
Awards & highlights

Study Summary

This trial aims to compare two types of behavioral interventions, Behavioral Activation and Relapse Prevention, in U.S. military veterans with both alcohol use disorder (AUD) and posttraumatic stress disorder (PT

Who is the study for?
This trial is for U.S. military veterans who are dealing with both alcohol use disorder (AUD) and posttraumatic stress disorder (PTSD). Participants should be willing to undergo interviews, self-report measures, and geospatial assessments before and after the treatment.Check my eligibility
What is being tested?
The study compares two treatments: Behavioral Activation (BA), adapted specifically for veterans with AUD/PTSD, against Relapse Prevention (RP). Each participant receives 8 sessions of one treatment type, decided randomly.See study design
What are the potential side effects?
Since BA and RP are behavioral interventions rather than medications, they may not have typical 'side effects' but could include emotional discomfort or distress during therapy sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Clinician-Administered PTSD Scale for DSM-5 (PTSD severity)
Timeline Follow-Back (alcohol use)
Secondary outcome measures
Brief Inventory of Psychosocial Functioning (psychosocial functioning)
Generalized Anxiety Disorder-7 (GAD-7)
Geospatial activity
+3 more

Side effects data

From 2016 Phase 3 trial • 221 Patients • NCT01299766
5%
Death NOS
4%
Knee replacement
4%
Stroke
2%
bypass surgery
2%
Heart attack
2%
Pacemaker implanted
2%
COPD
2%
GI symptoms
1%
infection
1%
Breast cancer
1%
hypoglycemia
1%
Edema
1%
Fracture
1%
Broken shoulder
1%
Valve replacement
1%
Asthma Attack
1%
Prostate cancer
1%
colon cancer
1%
Blood clot
1%
pneumonia
1%
Hernia repair
1%
Seziure
1%
CHF
1%
aneurysm
1%
Depression
100%
80%
60%
40%
20%
0%
Study treatment Arm
Behavior Activation
Supportive Therapy (ST)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Behavioral Activation (BA)Experimental Treatment1 Intervention
Individual psychotherapy
Group II: Relapse Prevention (RP)Active Control1 Intervention
Individual psychotherapy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Behavioral Activation (BA)
2014
Completed Phase 3
~350

Find a Location

Who is running the clinical trial?

National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
801 Previous Clinical Trials
1,365,351 Total Patients Enrolled
423 Trials studying Alcoholism
985,662 Patients Enrolled for Alcoholism
Duke UniversityOTHER
2,363 Previous Clinical Trials
3,420,460 Total Patients Enrolled
5 Trials studying Alcoholism
2,707 Patients Enrolled for Alcoholism
RTI InternationalLead Sponsor
188 Previous Clinical Trials
875,918 Total Patients Enrolled
6 Trials studying Alcoholism
1,889 Patients Enrolled for Alcoholism

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can individuals younger than 55 years of age participate in this study?

"This research study is seeking participants who are beyond 18 years old yet under 65 years of age."

Answered by AI

What is the primary objective of this investigation?

"This study aims, throughout its approximate 3-month duration until completion, to assess alcohol consumption using the Timeline Follow-Back method. Additional objectives include evaluating changes in psychosocial functioning with the Brief Inventory of Psychosocial Functioning from baseline to post-treatment, assessing depressive symptom severity using Patient Health Questionnaire-9 from baseline to posttreatment, and measuring sleep disturbance through the Insomnia Severity Index over this same period."

Answered by AI

Is the ongoing medical study actively seeking participants at this time?

"Information on clinicaltrials.gov states that this particular research project is not actively seeking volunteers. This trial was initially shared on April 1, 2024, and last revised on February 7, 2024. While recruitment for this study has concluded, there are currently a significant number of other studies open for participant enrollment - amounting to approximately 767 ongoing trials."

Answered by AI
~31 spots leftby Nov 2025